We are presenting a poster at the ESMO Breast Cancer Annual Congress (#ESMOBreast23) from 11-13 May in Berlin. The poster demonstrates that the Digistain Prognostic Score showed high accuracy and predictive performance, and stratified patients with early breast cancer into low or high risk. The low cost, rapidity and accessibility of Digistain’s technology approach has potential as an alternative or addition to existing prognostic tools across real-life clinical practice, including under-resourced settings.
Digistain Presents Key Research Findings at the San Antonio Breast Cancer Symposium 2024
Last week, we were proud to present two abstracts at the San Antonio Breast Cancer Symposium 2024. The first abstract showcased head-to-head data from Charing
